Differences in the covalent binding of benzo[a]pyrene, safrole, 1′-hydroxysafrole, and 4-aminobiphenyl to DNA of pregnant and non-pregnant mice

Leejane Lu, Rose M. Disher, Kurt Randerath

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The effects of pregnancy on the covalent binding of several carcinogens to DNA were investigated in mice. Non-pregnant or timed-pregnant (18th day of gestation) ICR mice of similar age were treated with benzo[a]pyrene (BP, 200 μmol/kg), safrole (600 μmol/kg), 1′-hydroxysafrole (400 μmol/kg), 4-aminobiphenyl (4-ABP, 800 μmol/kg), or trioctanoin (4 ml/kg) per os. Tissue DNA adduct levels at 24 h after carcinogen treatment were analyzed via a 32P-postlabeling assay. Pregnancy lowered the binding of the ultimate carcinogenic metabolite of BP, 7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE I), to liver and lung DNA by 29-41%, but not the binding of other metabolites. The binding of safrole and its proximate carcinogen, 1′-hydroxysafrole, to liver and kidney DNA was increased 2.3-3.5 fold. Pregnancy decreased the binding of 4-ABP to liver DNA by ∼18% but increased its binding to kidney DNA by 67%. The results suggest that exposure to some genotoxic compounds, especially those requiring conjugation reactions for metabolic activation, may be more hazardous during pregnancy than in the non-pregnant state.

Original languageEnglish (US)
Pages (from-to)43-52
Number of pages10
JournalCancer Letters
Volume31
Issue number1
DOIs
StatePublished - 1986
Externally publishedYes

Fingerprint

Safrole
Benzo(a)pyrene
Pregnancy
Carcinogens
DNA
Liver
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide
Kidney
Inbred ICR Mouse
DNA Adducts
4-biphenylamine
1'-hydroxysafrole
Lung

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Biology
  • Oncology

Cite this

Differences in the covalent binding of benzo[a]pyrene, safrole, 1′-hydroxysafrole, and 4-aminobiphenyl to DNA of pregnant and non-pregnant mice. / Lu, Leejane; Disher, Rose M.; Randerath, Kurt.

In: Cancer Letters, Vol. 31, No. 1, 1986, p. 43-52.

Research output: Contribution to journalArticle

@article{5b6ce698c35046aeab02d6338436220c,
title = "Differences in the covalent binding of benzo[a]pyrene, safrole, 1′-hydroxysafrole, and 4-aminobiphenyl to DNA of pregnant and non-pregnant mice",
abstract = "The effects of pregnancy on the covalent binding of several carcinogens to DNA were investigated in mice. Non-pregnant or timed-pregnant (18th day of gestation) ICR mice of similar age were treated with benzo[a]pyrene (BP, 200 μmol/kg), safrole (600 μmol/kg), 1′-hydroxysafrole (400 μmol/kg), 4-aminobiphenyl (4-ABP, 800 μmol/kg), or trioctanoin (4 ml/kg) per os. Tissue DNA adduct levels at 24 h after carcinogen treatment were analyzed via a 32P-postlabeling assay. Pregnancy lowered the binding of the ultimate carcinogenic metabolite of BP, 7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE I), to liver and lung DNA by 29-41{\%}, but not the binding of other metabolites. The binding of safrole and its proximate carcinogen, 1′-hydroxysafrole, to liver and kidney DNA was increased 2.3-3.5 fold. Pregnancy decreased the binding of 4-ABP to liver DNA by ∼18{\%} but increased its binding to kidney DNA by 67{\%}. The results suggest that exposure to some genotoxic compounds, especially those requiring conjugation reactions for metabolic activation, may be more hazardous during pregnancy than in the non-pregnant state.",
author = "Leejane Lu and Disher, {Rose M.} and Kurt Randerath",
year = "1986",
doi = "10.1016/0304-3835(86)90165-5",
language = "English (US)",
volume = "31",
pages = "43--52",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Differences in the covalent binding of benzo[a]pyrene, safrole, 1′-hydroxysafrole, and 4-aminobiphenyl to DNA of pregnant and non-pregnant mice

AU - Lu, Leejane

AU - Disher, Rose M.

AU - Randerath, Kurt

PY - 1986

Y1 - 1986

N2 - The effects of pregnancy on the covalent binding of several carcinogens to DNA were investigated in mice. Non-pregnant or timed-pregnant (18th day of gestation) ICR mice of similar age were treated with benzo[a]pyrene (BP, 200 μmol/kg), safrole (600 μmol/kg), 1′-hydroxysafrole (400 μmol/kg), 4-aminobiphenyl (4-ABP, 800 μmol/kg), or trioctanoin (4 ml/kg) per os. Tissue DNA adduct levels at 24 h after carcinogen treatment were analyzed via a 32P-postlabeling assay. Pregnancy lowered the binding of the ultimate carcinogenic metabolite of BP, 7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE I), to liver and lung DNA by 29-41%, but not the binding of other metabolites. The binding of safrole and its proximate carcinogen, 1′-hydroxysafrole, to liver and kidney DNA was increased 2.3-3.5 fold. Pregnancy decreased the binding of 4-ABP to liver DNA by ∼18% but increased its binding to kidney DNA by 67%. The results suggest that exposure to some genotoxic compounds, especially those requiring conjugation reactions for metabolic activation, may be more hazardous during pregnancy than in the non-pregnant state.

AB - The effects of pregnancy on the covalent binding of several carcinogens to DNA were investigated in mice. Non-pregnant or timed-pregnant (18th day of gestation) ICR mice of similar age were treated with benzo[a]pyrene (BP, 200 μmol/kg), safrole (600 μmol/kg), 1′-hydroxysafrole (400 μmol/kg), 4-aminobiphenyl (4-ABP, 800 μmol/kg), or trioctanoin (4 ml/kg) per os. Tissue DNA adduct levels at 24 h after carcinogen treatment were analyzed via a 32P-postlabeling assay. Pregnancy lowered the binding of the ultimate carcinogenic metabolite of BP, 7β,8α-dihydroxy-9α,10α-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE I), to liver and lung DNA by 29-41%, but not the binding of other metabolites. The binding of safrole and its proximate carcinogen, 1′-hydroxysafrole, to liver and kidney DNA was increased 2.3-3.5 fold. Pregnancy decreased the binding of 4-ABP to liver DNA by ∼18% but increased its binding to kidney DNA by 67%. The results suggest that exposure to some genotoxic compounds, especially those requiring conjugation reactions for metabolic activation, may be more hazardous during pregnancy than in the non-pregnant state.

UR - http://www.scopus.com/inward/record.url?scp=0022520598&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022520598&partnerID=8YFLogxK

U2 - 10.1016/0304-3835(86)90165-5

DO - 10.1016/0304-3835(86)90165-5

M3 - Article

C2 - 3697953

AN - SCOPUS:0022520598

VL - 31

SP - 43

EP - 52

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -